Polaryx Therapeutics Says It Remains On Track To Initiate Phase 2 SOTERIA Basket Trial Of PLX-200 In Four Pediatric Lysosomal Storage Disorders In Q4 2026

Benzinga Newsdesk www.benzinga.com Positive 78.8%

Neg 0% Neu 0% Pos 78.8%

Comments

No comments yet. Be the first!